Skin cancer is the most prevalent cancer in the United States, affecting approximately 20% of Americans, with rates increasing annually [1]. By 2040, malignant melanoma is projected to be the second leading cancer [2]. While the majority of skin cancers have low morbidity and mortality, malignant melanoma causes significant morbidity and mortality, accounting for 80% of skin cancer related deaths [3]. Because early-stage melanomas have improved outcomes, early detection and treatment is imperative. However, the 2023 United States Preventative Task Force (USPTF) called for more research in order to determine skin cancer screening recommendations and made a grade B recommendation for counseling 6-month to 24-year-olds regarding minimizing exposure to Ultraviolet (UV) radiation with fair skin to prevent skin cancer [4].
No takes yet. Share an insight, caveat, or question.
Maloney et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: